The FDA has issued a safety alert for Tavneos, a medication used to treat a rare autoimmune disease, due to recent reports ...
US regulators urge patients to discuss with clinicians the risks of avacopan and to consider an alternative treatment to this medicine, which is approved for a rare autoimmune disease.
MedPage Today on MSN
FDA warns of fatal liver injuries tied to drug it wants pulled from market
Eight deaths and dozens of DILI cases linked to avacopan for ANCA-associated vasculitis ...
Amgen drug under FDA review Tavneos is linked to 76 liver injury cases including eight deaths; FDA advises liver monitoring ...
The investigators assessed temporal changes in patterns of induction therapy, and evaluated short-term renal and survival outcomes, as well as safety outcomes, prior to and following the introduction ...
Canada: A recent study published in JAMA Network Open suggests that while hydralazine use may be linked to a slightly higher ...
Ashton Kutcher's recent revelation about his vasculitis diagnosis is bringing to light to an autoimmune disorder that can cause serious damage to the body. According to the 44-year-old, he's "lucky to ...
Vasculitis is a rare but serious condition that involves inflammation of the blood vessels. This inflammation can affect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results